Physician

Adam S Zivony, M.D.

According to 2025 Medicare claims, Adam Zivony, M.D. (NPI: 1972717171) practices gastroenterology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is DIGESTIVE HEALTH PARTNERS, PA (NPI: 1326037680; TIN: 561150163) and primary practice location at 28801-4109. Zivony is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Zivony's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 464 traditional Medicare patients, billed 8,128 HCPCS/CPT codes, and received $204,137 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 506 prescription claims across 256 beneficiaries totaling $159,563 in drug costs, led by Ursodiol (Ursodiol). Open Payments data shows 76 records totaling $70,473. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $28,510 to $204,137. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,896 and ending at $159,563. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	143	348	$28,510
2016	531	3,404	$117,115
2017	574	2,037	$126,772
2018	617	4,156	$143,234
2019	591	7,366	$171,172
2020	522	5,681	$152,554
2021	567	7,077	$170,762
2022	543	9,559	$204,235
2023	556	9,023	$221,459
2024	464	8,128	$204,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	33	$2,896
2016	181	308	$224,549
2017	262	577	$1,039,718
2018	375	846	$586,663
2019	381	923	$524,917
2020	357	888	$484,857
2021	446	991	$275,747
2022	479	963	$413,520
2023	536	935	$365,887
2024	256	506	$159,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	148	150	$199
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	66	66	$99
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	34	34	$95
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	65	65	$77
43235	Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope	37	37	$69

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ursodiol	Ursodiol	28	2,100	$7,473
Suflave	Peg 3350/Sod Sulf,chlr/Pot/Mag	26	43	$3,138
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	27	46	$1,926
Tacrolimus	Tacrolimus	16	900	$1,894
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	68	112	$1,179

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	74	$24,855	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$45,618	Intercept Pharma Europe Ltd.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam S. Zivony, M.D.?

Tedicare shows public-source Medicare data for Adam S. Zivony, M.D. (NPI 1972717171), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam S. Zivony, M.D. have ACO affiliation data?

Adam S. Zivony, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Adam S. Zivony, M.D.?

Adam S. Zivony, M.D. is linked to DIGESTIVE HEALTH PARTNERS, PA (billing NPI 1326037680) in the available physician profile data.

Does Adam S. Zivony, M.D. have Open Payments data?

Adam S. Zivony, M.D. has 76 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.